State Key Laboratory of Natural Medicines, Jiangsu Province Key Laboratory of Drug Metabolism, China Pharmaceutical University, Nanjing, 210009, China.
State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
J Mater Chem B. 2024 Sep 25;12(37):9213-9228. doi: 10.1039/d4tb00914b.
Human umbilical cord mesenchymal stem cells (HUCMSCs) are applied for disease therapy as a new type of drug in many countries. Their effects are not only presented by live cells, but also apoptotic bodies or cell fragments of dead cells. Therefore, it is meaningful to determine the multiple fates of HUCMSCs . Although various probes combining different imaging modalities have been developed to label and trace transplanted HUCMSCs , the status of the cells (live, dead, or apoptotic) was not distinguished, and a thorough understanding of the multiple fates of HUCMSCs after transplantation is lacking. Therefore, a magnetic resonance (MR)/near infrared fluorescent (NIRF)/bioluminescence (BI) multi-modality imaging strategy was developed. Iron oxide nanoparticles (IONPs) were assembled into 100 nm nanoparticles using epigallocatechin gallate as a chemical linker to increase the MR signal and reduce the exocytosis of IONPs for direct cell labeling and longitudinal MR imaging tracking. Fluorescent probes for apoptosis (DEVD-Cy-OH) were also loaded in the above assemblies to monitor the cell status. Meanwhile, the cell surface was labeled with the fluorescent dye Cy7 bioorthogonal reactions to visualize the NIRF signal. Luciferase was lentivirally transfected into live cells to generate bioluminescence. Such labeling did not affect either the viability, proliferation, migration, differentiation characteristics of HUCMSCs or their therapeutic effects on acute liver injury mice . The fates of HUCMSCs were monitored MR/NIRF/BI multi-modality imaging in acute liver injury mice. Although MR and Cy7 signals aggregated in injured liver for 7 days, the BI signals persisted for less than 24 hours. There was an increase in DEVD-Cy-OH signals in the injured liver, but they were almost at the basal level. That means that HUCMSCs survive in mice for a short time, and the dead form of HUCMSCs accumulated in a large quantity and sustained for a long time, which might contribute to their therapeutic effect.
人脐带间充质干细胞(HUCMSCs)作为一种新型药物在许多国家被应用于疾病治疗。其作用不仅表现为活细胞,还表现为凋亡小体或死亡细胞的细胞碎片。因此,确定 HUCMSC 的多种命运具有重要意义。尽管已经开发出各种结合不同成像模式的探针来标记和追踪移植的 HUCMSCs,但细胞的状态(存活、死亡或凋亡)无法区分,对移植后 HUCMSC 的多种命运缺乏深入了解。因此,开发了一种磁共振(MR)/近红外荧光(NIRF)/生物发光(BI)多模态成像策略。使用表没食子儿茶素没食子酸酯作为化学连接物将氧化铁纳米颗粒(IONPs)组装成 100nm 纳米颗粒,以增加 MR 信号并减少 IONPs 的胞吐作用,从而进行直接细胞标记和纵向 MR 成像跟踪。还将凋亡的荧光探针(DEVD-Cy-OH)加载到上述组装体中以监测细胞状态。同时,细胞表面用荧光染料 Cy7 进行生物正交反应以可视化 NIRF 信号。荧光素酶通过慢病毒转染到活细胞中以产生生物发光。这种标记不会影响 HUCMSC 的活力、增殖、迁移和分化特性,也不会影响其对急性肝损伤小鼠的治疗效果。通过 MR/NIRF/BI 多模态成像在急性肝损伤小鼠中监测 HUCMSC 的命运。尽管 MR 和 Cy7 信号在 7 天内聚集在受损的肝脏中,但 BI 信号持续时间不到 24 小时。在受损的肝脏中,DEVD-Cy-OH 信号增加,但几乎处于基础水平。这意味着 HUCMSC 在小鼠体内存活时间短,大量死亡形式的 HUCMSC 持续时间长,这可能有助于其治疗效果。